Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: M. Ramle who wrote (869)	6/2/1998 9:32:00 PM
From: Biomaven	Read Replies (1) of 10280

Mazen, I can't believe the Prozac/Effexor study had anything at all to do with SEPR's price performance over the last few days. SEPR's ICE for Prozac is just a nice "what-if" at this point. It would be great if they can do a deal with Lilly, but whether they do so or not, and the impact of any such deal, is independent of marginal changes in efficacy claims between Prozac and the other SSRI's. At this point, I'm sticking with my guess that we'll see some analyst push some estimates of near-term earnings further out, and that this is the cause of the weakness. We've seen sudden weakness in SEPR stock before for no rhyme or reason, and this could of course be another of those instances. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next